A report from People’s Daily: The first flights under China’s new COVID-19 management for international travelers arrived at…
Blog
Xenia Venture Capital Ltd. Is announcing iTind Procedure for Treatment of BPH, Awarded New Code Payment Rate for the Procedure in the US
Xenia Venture Capital Ltd., ( www.xenia.co.il) an Israeli investment company engaged in the establishment, development, and investment…
Point of Care Molecular Diagnostics Market Research Report by Product, Technology, Application, End-User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19
The Global Point of Care Molecular Diagnostics Market size was estimated at USD 389.12 million in 2021 and…
Nutrisystem® Offers Comprehensive, Low Cost and Science-Based Plans for 2023 Helping Consumers Lose Weight and Eat Healthy as Prices Rise at the Grocery Store
As prices continue to rise at grocery stores nationwide, Nutrisystem®, a division of Wellful, Inc. and a leading provider of…
PVmed Raises US $14 Million Series A Funding from Cherami, Philips, JHF, COCOCAPITAL, and Strategy Capital
– Perception Vision Medical Technologies Co., Ltd. (PVmed), a global artificial intelligence (AI) cancer treatment company,…
Low-Carb Diet Market to Perceive Remarkable Growth of 18.65 Billion by 2029, Size, Share, Trends, Demand, Opportunities, Challenges and Revenue Analysis
Data Bridge Market Research has recently published a Report, titled, “Low-Carb Diet Market” The report offers an…
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2022 Financial Results and Provides Business Update
$41.7 million in cash and cash equivalents as of September 30, 2022; extends runway through December 2023 Mino-Lok® Phase…
Neurocrine Biosciences Announces U.S. FDA Accepts Supplemental New Drug Application for Valbenazine as a Treatment for Chorea Associated with Huntington Disease
Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced that the U.S. Food and Drug…
Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative…
Asep Medical Holdings Inc. Achieves Significant Milestones Addressing Antibiotic Failure Through Proprietary Diagnostic & Therapeutic Technologies
Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, through…